What do studies and guidelines suggest as successful therapeutic strategies for RA patients who have been inadequate responders to TNF therapy?

What do studies and guidelines suggest as successful therapeutic strategies for RA patients who have been inadequate responders to TNF therapy?

What do studies and guidelines suggest as successful therapeutic strategies for RA patients who have been inadequate responders to TNF therapy? On the basis of what criteria is the decision made to switch to an Il-6 inhibitor or an agent with an alternative MoA?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Yvonne Sherrer, MD

Yvonne Sherrer, MD

Medical Director/Director of Clinical Research
Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, FL